Multicentre, open, noncomparative Phase II trial to evaluate the efficacy and tolerability of fotemustine, cisplatin, alpha-interferon and interleukin-2 in advanced melanoma patients-Reference-Cited by-同舟云学术

Multicentre, open, noncomparative Phase II trial to evaluate the efficacy and tolerability of fotemustine, cisplatin, alpha-interferon and interleukin-2 in advanced melanoma patients

Published:2009-04 Issue:2 Volume:19 Page:100-105
ISSN:0960-8931
Container-title:Melanoma Research
language:en
Short-container-title:

Author:

Ridolfi Laura,Fiorentini Giammaria,Guida Michele,Michiara Maria,Freschi Andrea,Aitini Enrico,Ballardini Michela,Bichisao Ettore,Ridolfi Ruggero

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Dermatology,Oncology

Reference36 articles.

1. Global cancer statistics, 2002;Parkin;CA Cancer J Clin,2005

2. Systemic therapy in melanoma;Nathan;Semin Surg Oncol,1998

3. Medical management of stage IV malignant melanoma;Ho;Cancer,1995

4. Duration of survival for disseminated malignant melanoma: results of a meta-analysis;Lee;Melanoma Res,2000

5. Metastatic melanoma: chemotherapy;Bajetta;Semin Oncol,2002

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Network of Cytokines in Brain Metastases;Cancers;2021-01-05

2. Multidisciplinary Approach to Patient with Malignant Melanoma;Anti-Cancer Agents in Medicinal Chemistry;2013-06-01

3. Chemotherapy in the management of brain metastases: the emerging role of fotemustine for patients with melanoma and NSCLC;Expert Opinion on Drug Safety;2013-04-08

4. Immunotherapy for treating metastatic colorectal cancer;Surgical Oncology;2012-06

5. Inhibitory Effects of the AttenuatedSalmonella typhimuriumContaining the IL-2 Gene on Hepatic Tumors in Mice;Journal of Biomedicine and Biotechnology;2012